Latest Diabetic Nephropathy News
Prediction independent of traditional risk factors such as MetS, glucose, HbA1c in general population
Significant additive interaction identified for night shift work, unhealthy lifestyle for female nurses
Report provides guidance on reducing CV risk in patients with T2DM and atherosclerotic CV disease
Using higher HbA1c target in over-75s could increase disability-adjusted life-years by 44.2%.
Delays in seeking care for first major symptom of macrovascular disease, first major diagnostic test.
SGLT2i reduced the risks for progression of renal disease by 45% and heart failure hospitalization by 31% in patients with type 2 diabetes.
Risk increased for lower-limb amputation, diabetic ketoacidosis compared with GLP1 receptor agonists.
Lower all-cause mortality in CABG group vs PCI-DES group after median follow-up of 7.5 years.
For patients with prediabetes, changes in risk indicators during intervention tied to T2DM, CVD risk
Treatment resulted in lower HF hospitalization rate in patients with, without atherosclerosis.
Treatment with bardoxolone methyl resulted in significant weight loss and showed no evidence of muscle wasting in patients with type 2 diabetes and stage IV chronic kidney disease.
Strict BP control, fenofibrate use may increase long-term risk for adverse kidney events in T2DM patients
In a study, reduced mortality was found among TRT users with type 2 diabetes after adjustment for cardiovascular risk factors.
The effect of Invokana on CV risk was evaluated in the CANVAS (CANagliflozin cardioVascular Assessment Study) Program in >10,000 adults with T2D who had established CV disease or were at risk for CV disease with ≥2 risk factors.
Canagliflozin vs placebo is associated with increased survival and renal outcomes in patients with type 2 diabetes and macroalbuminuria.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)
Renal and Urology News Articles
- Gadolinium-Based Contrast May Up Acute Kidney Injury Risk in CKD
- Delayed Prostate Cancer Treatment May Up Relapse Risk
- Review: Desmopressin Decreases Nocturia Episodes
- Surgery, Radiation Regimens for High-Grade PCa Offer Similar Outcomes
- Salvage Prostatectomy May Benefit Some Prostate Cancer Patients